Hoenle AG (XETRA:HNL.DE)
| Market Cap | 45.83M-10.8% |
| Revenue (ttm) | n/a-3.7% |
| Net Income | n/a+78.6% |
| EPS | n/a+78.8% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 32 |
| Open | 7.56 |
| Previous Close | 7.56 |
| Day's Range | 7.56 - 7.56 |
| 52-Week Range | 6.48 - 11.90 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About HNL.DE
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing paints, varnishes, and other coatings for printing, packaging printing, coating, and printing on three dimensional objects industries. The Disinfection segment is involved in activities in the areas of industrial water, surface, and air disinfection, including microbiological testing for various applications comprising disinfection in food industry, special lamps for life science, custom lamps, and microbiologic analyses. It serves aerospace, automotive, consumer electronics, environmental, food, health and medical technology, print, and semiconductor industries. The company was formerly known as Dr. Hönle AG and changed its name to Hoenle AG. The company was founded in 1976 and is headquartered in Gilching, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$HNL.DE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in HNL.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by HNL.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
HNL.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New HNL.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to HNL.DE from public contracts
Source: USAspending.gov
HNL.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from HNL.DE’s recent data — informational, not investment advice